CN Patent

CN103497188B — 调节c‑fms和/或c‑kit活性的化合物及其应用

Assigned to First Three Co.,Ltd. · Expires 2017-06-23 · 9y expired

What this patent protects

本文提供了对受体蛋白酪氨酸激酶c‑kit和／或c‑fms具有活性的化合物。本文也提供了用于治疗c‑kit介导的疾病或病症和／或c‑fms介导的疾病或病症的组合物，以及它们的应用方法。

USPTO Abstract

本文提供了对受体蛋白酪氨酸激酶c‑kit和／或c‑fms具有活性的化合物。本文也提供了用于治疗c‑kit介导的疾病或病症和／或c‑fms介导的疾病或病症的组合物，以及它们的应用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103497188B
Jurisdiction
CN
Classification
—
Expires
2017-06-23
Drug substance claim
No
Drug product claim
No
Assignee
First Three Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.